Qube Research & Technologies LTD Outset Medical, Inc. Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Outset Medical, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 10,306 shares of OM stock, worth $5,668. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,306
Previous 25,836
60.11%
Holding current value
$5,668
Previous $17,000
35.29%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding OM
# of Institutions
86Shares Held
17.4MCall Options Held
46.5KPut Options Held
57.2K-
Vanguard Group Inc Valley Forge, PA2.61MShares$1.43 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA1.47MShares$809,4380.08% of portfolio
-
Morgan Stanley New York, NY1.44MShares$789,9490.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.39MShares$766,2870.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.29MShares$710,1340.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $26.4M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...